Elena N. Pavlyukova

Elena N. Pavlyukova

Auto-generated profile, based on publicly available information

Elena N. Pavlyukova

Meshalkin National Medical Research Center

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2016 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Closed access
PDF file
SASergey A. Afanasiev
Sergey A. Afanasiev
EPElena N. Pavliukova
Elena N. Pavliukova
MKMaria A. Kuzmichkina
Maria A. Kuzmichkina
TRT. Yu. Rebrova
T. Yu. Rebrova
Nina D. AnfinogenovaNina D. Anfinogenova
Nina D. Anfinogenova
RKRostislav S. Karpov
Rostislav S. Karpov

Verified
Journal Article
Open access
PDF file
Ramil SalakhovRamil Salakhov
Ramil Salakhov
MGMaria V. Golubenko
Maria V. Golubenko
NVNail R. Valiakhmetov
Nail R. Valiakhmetov
EPElena N. Pavlyukova
Elena N. Pavlyukova
AZAlexei Zarubin
Alexei Zarubin
NMNazarenko Maria
Nazarenko Maria
Increasing evidence suggests that both coding and non-coding regions of sarcomeric protein genes can contribute to hypertrophic cardiomyopathy (HCM). Here, we introduce an experimental workflow (tested on four patients) for complete sequencing of the most common HCM genes (MYBPC3, MYH7, TPM1, TNNT2, and TNNI3) via long-range PCR, Oxford Nanopore Technology (ONT) sequencing, and bioinformatic analysis. We applied Illumina and Sanger sequencing to validate the results, FastQC, Qualimap, and MultiQC for quality evaluations, MiniMap2 to align data, Clair3 to call and phase variants, and Annovar’s tools and CADD to assess pathogenicity of variants. We could not amplify the region encompassing exons 6–12 of MYBPC3. A higher sequencing error rate was observed with ONT (6.86–6.92%) than with Illumina technology (1.14–1.35%), mostly for small indels. Pathogenic variant p.Gln1233Ter and benign polymorphism p.Arg326Gln in MYBPC3 in a heterozygous state were found in one patient. We demonstrated the ability of ONT to phase single-nucleotide variants, enabling direct haplotype determination for genes TNNT2 and TPM1. These findings highlight the importance of long-range PCR efficiency, as well as lower accuracy of variant calling by ONT than by Illumina technology; these differences should be clarified prior to clinical application of the ONT method.

31 December 2019 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
VSViktoria I Skidan
Viktoria I Skidan
TKTatiana Kuznetsova
Tatiana Kuznetsova
EPElena N Pavlyukova
Elena N Pavlyukova
GNGalina P Nartsissova
Galina P Nartsissova
Background: Isolated left ventricular apical hypoplasia (ILVAH) is a rare congenital cardiac abnormality, which might result in severe symptomatic heart failure (HF) with pulmonary hypertension, atrial fibrillation (AF), or malignant ventricular tachycardia in adults. Case summary: A 32-years-old man presented with exertional dyspnoea New York Heart Association Class II and persistent AF. Echocardiography and cardiac magnetic resonance showed the presence of (i) spherical remodelling of the left ventricle (LV) with impaired contractile function (three-dimensional ejection fraction, EF 32%); (ii) substitution of apical myocardium by fatty tissue; (iii) abnormal origin of a papillary muscle network; and (iv) an elongated right ventricle, compatible with ILVAH. In addition, non-compacted endomyocardial layer of the LV was observed. Because of a high risk of sudden cardiac death in symptomatic HF patients with reduced EF, an implantable cardioverter-defibrillator was placed which followed by pulmonary vein isolation. After the procedures and restoration of sinus rhythm, the patient demonstrated improvement in HF symptoms and exercise tolerance. This was accompanied by an enhancement of left and right ventricular systolic function by echocardiography. At 6-month, 1, and 2-year follow-up the clinical conditions of the patient and echocardiographic findings remained stable. Discussion: A rare combination of ILVAH and left ventricular myocardium non-compaction was observed in this young adult who presented with symptomatic HF and persistent AF. The use of consecutive invasive cardiac procedures leads to restoration of sinus rhythm, the improvement of myocardial contractility and clinical manifestation of HF.

23 February 2024 in Frontiers in Bioscience-Scholar
Verified
Journal Article
Open access
PDF file
MGMaria V. Golubenko
Maria V. Golubenko
EPElena N. Pavlyukova
Elena N. Pavlyukova
Ramil SalakhovRamil Salakhov
Ramil Salakhov
OMOksana A. Makeeva
Oksana A. Makeeva
KPKonstantin V. Puzyrev
Konstantin V. Puzyrev
NMNazarenko Maria
Nazarenko Maria
Background: Hypertrophic cardiomyopathy is the most frequent autosomal dominant disease, yet due to genetic heterogeneity, incomplete penetrance, and phenotype variability, the prognosis of the disease course in pathogenic variant carriers remains an issue. Identifying common patterns among the effects of different genetic variants is important. Methods: We investigated the cause of familial hypertrophic cardiomyopathy (HCM) in a family with two patients suffering from a particularly severe disease. Searching for the genetic variants in HCM genes was performed using different sequencing methods. Results: A new missense variant, p.Leu714Arg, was identified in exon 19 of the beta-myosin heavy chain gene (MYH7). The mutation was found in a region that encodes the ‘converter domain’ in the globular myosin head. This domain is essential for the conformational change of myosin during ATP cleavage and contraction cycle. Most reports on different mutations in this region describe severe phenotypic consequences. The two patients with the p.Leu714Arg mutation had heart failure early in life and died from HCM complications. Conclusions: This case presents a new likely pathogenic variant in MYH7 and supports the hypothesis that myosin converter mutations constitute a subclass of HCM mutations with a poor prognosis for the patient.

28 March 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
EPE. N. Pavlyukova
E. N. Pavlyukova
DKD. A. Kuzhel
D. A. Kuzhel
Heart failure (HF) with preserved ejection fraction (HFpEF) is currently the most common type of this condition, especially among elderly patients. Despite the preserved left ventricular (LV) and a moderate increase in natriuretic peptide, patients with HFpEF have the same out-of-hospital mortality as those with HF with reduced ejection fraction (HFrEF). Diagnosis of HFpEF is difficult due to nonspecific symptoms, expensive blood tests, and questionable rest echocardiographic data on diastolic function. In addition, the reason for poor diagnosis of HfpEF in clinical practice may be old age and comorbidities, which can also cause nonspecific symptoms of moderate chronic shortness of breath, weakness, and palpitations. The consequence is the detection of HFpEF only in every fourth patient with an acute or chronic heart failure. The use of simplified clinical diagnostic protocols along with a non-invasive ultrasound stress test can help overcome the existing problems in the diagnosis of HFpEF.

6 April 2021 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
Alexey EvtushenkoAlexey Evtushenko
Alexey Evtushenko
Alexey EvtushenkoAlexey Evtushenko
Alexey Evtushenko
EPE. N. Pavlyukova
E. N. Pavlyukova
TSTatiana E. Suslova
Tatiana E. Suslova
AGAnna Gusakova
Anna Gusakova
SPSergey Popov
Sergey Popov
Дисфункция синусового узла у пациентов с длительно персистирующей фибрилляцией предсердий: клинико-лабораторные параллели